Kline GA, Prebtani APH, Leung AA, Schiffrin EL. Primary aldosteronism: a common cause of resistant hypertension. CMAJ. 2017;189(22):E773–8.

PubMed  PubMed Central  Google Scholar 

Funder JW, Carey RM, Mantero F, et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2016;101(5):1889–916.

PubMed  Google Scholar 

Rossi GP, Auchus RJ, Brown M, et al. An expert consensus statement on use of adrenal vein sampling for the subtyping of primary aldosteronism. Hypertens (Dallas Tex: 1979). 2014;63(1):151–60.

Google Scholar 

Reincke M, Bancos I, Mulatero P, Scholl UI, Stowasser M, Williams TA. Diagnosis and treatment of primary aldosteronism. Lancet Diabetes Endocrinol. 2021;9(12):876–92.

PubMed  Google Scholar 

Ding J, Zhang Y, Wen J, et al. Imaging CXCR4 expression in patients with suspected primary hyperaldosteronism. Eur J Nucl Med Mol Imaging. 2020;47(11):2656–65.

PubMed  Google Scholar 

Simone G, Anceschi U, Tuderti G, et al. Robot-assisted partial adrenalectomy for the treatment of Conn’s syndrome: surgical technique, and perioperative and functional outcomes. Eur Urol. 2019;75(5):811–6.

PubMed  Google Scholar 

Fu B, Zhang X, Wang GX, et al. Long-term results of a prospective, randomized trial comparing retroperitoneoscopic partial versus total adrenalectomy for aldosterone producing adenoma. J Urol. 2011;185(5):1578–82.

PubMed  Google Scholar 

Anceschi U, Tuderti G, Fiori C, et al. Minimally invasive partial versus total adrenalectomy for the treatment of primary aldosteronism: results of a multicenter series according to the PASO criteria. Eur Urol Focus. 2021;7(6):1418–23.

PubMed  Google Scholar 

Nagaraja V, Eslick GD, Edirimanne S. Recurrence and functional outcomes of partial adrenalectomy: a systematic review and meta-analysis. Int J Surg (London England). 2015;16(Pt A):7–13.

Google Scholar 

Ishidoya S, Ito A, Sakai K, et al. Laparoscopic partial versus total adrenalectomy for aldosterone producing adenoma. J Urol. 2005;174(1):40–3.

PubMed  Google Scholar 

Fernandes-Rosa FL, Giscos-Douriez I, Amar L, et al. Different somatic mutations in multinodular adrenals with Aldosterone-Producing adenoma. Hypertension. 2015;66(5):1014–22.

PubMed  Google Scholar 

Monticone S, Castellano I, Versace K, et al. Immunohistochemical, genetic and clinical characterization of sporadic aldosterone-producing adenomas. Mol Cell Endocrinol. 2015;411:146–54.

PubMed  PubMed Central  Google Scholar 

Mullen N, Curneen J, Donlon PT, et al. Treating primary Aldosteronism-Induced hypertension: novel approaches and future outlooks. Endocr Rev. 2024;45(1):125–70.

PubMed  Google Scholar 

Heinze B, Fuss CT, Mulatero P, et al. Targeting CXCR4 (CXC chemokine receptor type 4) for molecular imaging of Aldosterone-Producing adenoma. Hypertens (Dallas Tex: 1979). 2018;71(2):317–25.

Google Scholar 

Zhang X, Fu B, Lang B, et al. Technique of anatomical retroperitoneoscopic adrenalectomy with report of 800 cases. J Urol. 2007;177(4):1254–7.

PubMed  Google Scholar 

Williams TA, Lenders JWM, Mulatero P, et al. Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort. Lancet Diabetes Endocrinol. 2017;5(9):689–99.

PubMed  PubMed Central  Google Scholar 

Newcombe RG. Interval Estimation for the difference between independent proportions: comparison of eleven methods. Stat Med. 1998;17(8):873–90.

PubMed  Google Scholar 

Wu X, Senanayake R, Goodchild E, et al. [11 C]metomidate PET-CT versus adrenal vein sampling for diagnosing surgically curable primary aldosteronism: a prospective, within-patient trial. Nat Med. 2023;29(1):190–202.

PubMed  PubMed Central  Google Scholar 

Burton TJ, Mackenzie IS, Balan K, et al. Evaluation of the sensitivity and specificity of (11)C-metomidate positron emission tomography (PET)-CT for lateralizing aldosterone secretion by Conn’s adenomas. J Clin Endocrinol Metab. 2012;97(1):100–9.

PubMed  Google Scholar 

Gao Y, Ding J, Cui Y, et al. Functional nodules in primary aldosteronism: identification of CXCR4 expression with (68)Ga-pentixafor PET/CT. Eur Radiol. 2022.

Hu J, Xu T, Shen H, et al. Accuracy of Gallium-68 pentixafor positron emission tomography-Computed tomography for subtyping diagnosis of primary aldosteronism. JAMA Netw Open. 2023;6(2):e2255609.

PubMed  PubMed Central  Google Scholar 

Balci M, Tuncel A, Aslan Y, Aykanat C, Berker D, Guzel O. Laparoscopic partial versus total adrenalectomy in nonhereditary unilateral adrenal masses. Urol Int. 2020;104(1–2):75–80.

PubMed  Google Scholar 

Chen SF, Chueh SC, Wang SM, et al. Clinical outcomes in patients undergoing laparoscopic adrenalectomy for unilateral aldosterone producing adenoma: partial versus total adrenalectomy. J Endourol. 2014;28(9):1103–6.

PubMed  Google Scholar 

Lenders JW, Duh QY, Eisenhofer G, et al. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014;99(6):1915–42.

PubMed  Google Scholar 

Simforoosh N, Soltani MH, Shemshaki H, Bonakdar Hashemi M, Dadpour M, Kashi AH. Symptom resolution and recurrence outcomes after partial versus total laparoscopic adrenalectomy: 13 years of experience with Medium-Long term follow up. Urol J. 2020;18(2):165–70.

PubMed  Google Scholar 

Nakada T, Kubota Y, Sasagawa I, Yagisawa T, Watanabe M, Ishigooka M. Therapeutic outcome of primary aldosteronism: adrenalectomy versus enucleation of aldosterone-producing adenoma. J Urol. 1995;153(6):1775–80.

PubMed  Google Scholar 

Dekkers T, ter Meer M, Lenders JW, et al. Adrenal nodularity and somatic mutations in primary aldosteronism: one node is the culprit? J Clin Endocrinol Metab. 2014;99(7):E1341–1351.

PubMed  Google Scholar 

van de Wiel ECJ, Kusters B, Mann R, et al. Partial adrenalectomy carries a considerable risk of incomplete cure in primary aldosteronism. J Urol. 2021;206(2):219–28.

PubMed  Google Scholar 

Mete O, Erickson LA, Juhlin CC, et al. Overview of the 2022 WHO classification of adrenal cortical tumors. Endocr Pathol. 2022;33(1):155–96.

PubMed  PubMed Central  Google Scholar